| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.58B | +15.5% |
| Cost of Revenue | $668.0M | +26.8% |
| Gross Profit | $1.92B | +12.1% |
| R&D Expense | $607.0M | +3.8% |
| SG&A Expense | $497.0M | -5.2% |
| Operating Income | -$34.0M | +82.7% |
| Interest Expense | $18.0M | -50.0% |
| Pre-tax Income | $25.0M | +123.4% |
| Income Tax | $2.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $768.0M | -29.0% |
| Accounts Receivable | $149.0M | +43.3% |
| Current Assets | $2.12B | -9.1% |
| Total Assets | $5.68B | -2.5% |
| Current Liabilities | $679.0M | -18.3% |
| Total Liabilities | $801.0M | -18.3% |
| Stockholders' Equity | $4.88B | +0.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $368.0M | -14.0% |
| Capital Expenditures | $133.0M | -7.0% |
| Investing Cash Flow | -$6.0M | -101.5% |
| Financing Cash Flow | -$674.0M | +45.3% |
| Free Cash Flow | $235.0M | -17.5% |
| -60.0% |
| Net Income | $23.0M | +120.5% |
| EPS (Basic) | $0.09 | +118.8% |
| EPS (Diluted) | $0.09 | +118.8% |